化合物BRD4770 T1923
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1374601-40-7 | ¥1,080.00 | 询底价 |
1 mg | 1374601-40-7 | ¥295.00 | 询底价 |
50 mg | 1374601-40-7 | ¥3,490.00 | 询底价 |
2 mg | 1374601-40-7 | ¥418.00 | 询底价 |
100 mg | 1374601-40-7 | ¥5,120.00 | 询底价 |
1 mL | 1374601-40-7 | ¥739.00 | 询底价 |
5 mg | 1374601-40-7 | ¥673.00 | 询底价 |
25 mg | 1374601-40-7 | ¥1,920.00 | 询底价 |
Product Introduction
Bioactivity
英文名: BRD4770
描述: BRD4770 是组蛋白甲基转移酶G9a 抑制剂,可激活共济失调毛细血管扩张突变途径并诱导细胞衰老。它可抑制H3K9的二甲基和三甲基化,EC50为 5 µM。
细胞实验: PANC-1 cells are seeded and treated with BRD4770 in 6-well plates for 72 h. Cells are trypsinized and tested for soft agar colony formation using CytoSelect 96-Well Cell Transformation Assay, using the CyQuant GR dye to measure total cellular nucleic acid levels. Fluorescence is detected with an Analyst HT plate reader using a 485/520 nm filter set.(Only for Reference)
激酶实验: Biochemical activity of G9a: Dissociation Enhanced Lanthanide Fluoro-ImmunoAssays (DELFIA) are performed in white, opaque 384-well plates coated with Neutravidin. Test compounds are diluted to 12 μg/mL in 50 mM Tris-HCl pH 8.5 containing 4% DMSO and 10 μL is dispensed into the wells. Blank and control wells received only compound buffer. GST-G9a at 10 μg/mL and SAM at 40 μM are diluted in 50 mM Tris HCl pH 8.5/10 mM DTT and added in a volume of 20 μL. Blank wells receives Tris/DTT buffer only. The reactions are initiated by the addition of 800 nM H3(1-20)-cysbiotin substrate in 50 mM Tris pH 8.5 in a volume of 10 μl, and incubated at room temperature for 60 minutes. The plates are washed 3 times with 100 μl of Wash Buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween 20, 0.2% BSA). Next, 50 μl of Fluoroimmunoassay (FI) Buffer (50 mM Tris HCl pH 7.8, 150 mM NaCl, 0.05% Tween 40, 25 μM DTPA, 0.2% BSA, 0.05% BGG) containing 5ng α-2X-di-meth H3-K9 and 5ng goat anti-rabbit Eu chelate is added to all wells of the plate, and the plate is incubated for an additional hour at room temperature. The plates are washed 3 times with 100 μL of Wash Buffer, and 50 μL of Enhancement Solution is added to each well. Time resolved fluorescence is measured after 45 minutes on a Viewlux Microplate Imager imaging for 15 seconds with a 354 μs window, 400 μs delay, excitation at 360 nm, and emission at 618 nm.
体内活性: BRD4770和棉酚联用可以增加LC3-II水平和自噬体数量,从而协同作用诱导PANC-1细胞死亡。BRD4770在胰腺癌细胞系PANC-1中,通过通过抑制G9a降低二 - 和三甲基化H3K9的细胞水平,诱导衰老,并抑制贴壁依赖性和非依赖性增殖。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 8.3 mg/mL (20 mM)
关键字: EHMT2 | G9a | Histone Methyltransferase | BRD4770 | H3K9 | cell-permeable | ATR | chromatin | anti-proliferation | methylation | BRD-4770 | Inhibitor | ATM | senescent | inhibit | BRD 4770
相关产品: C-7280948 | WDR5-47 | GSK3368715 | PRMT5-IN-1 | LLY-507 | UNC3866 | EML734 | Ryuvidine | CPI-360 | DC-05
相关库: Anti-COVID-19 Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Epigenetics Compound Library | Target-Focused Phenotypic Screening Library | Stem Cell Differentiation Compound Library | Methylation Compound Library | NO PAINS Compound Library | Histone Modification Compound Library | Chromatin Modification Compound Library
化合物BRD4770 T1923信息由TargetMol中国为您提供,如您想了解更多关于化合物BRD4770 T1923报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途